journal article·2022-08Open access

Nano-engineered biomaterials: Safety matters and toxicity evaluation

J.C. Scimeca, E. Verron

Abstract

Nanotechnologies have invaded the field of tissue engineering including osteoarticular and dental tissue, and innovative biomaterials with topographic features engineered at the nanoscale have been designed to create nanostructures with mechanical and osteogenic properties. Nano-vehicles have also been developed and used as delivery systems for bio-actives compounds targeting bone tissue and preventing or treating locally skeletal diseases such as bone infections or tumors. While great advances have been reported in the design and production of these smart nanomaterials, their clinical translational remains a real challenge, mostly due to the limited predictive capacity of traditional preclinical safety tests. Safety issues specifically related to the nanometer scale have emerged, and new toxicity evaluation protocols need to be implemented. After providing an overview of the contribution of these encouraging therapeutic approaches, this review will focus on the specific safety concerns they raise, and toxicity evaluation will be discussed in terms of limits, challenges, and perspectives. Based on emerging technologies, recommendations are given to guarantee the robustness and the reproducibility of risk assessment procedures. Finally, we give a most recent update about nanomaterials safety guidelines.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticles: synthesis and applications · Graphene and Nanomaterials Applications · Bone Tissue Engineering Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. Biomaterials for bone regenerative engineering10.1002/adhm.201400760 ↗
2. Synthetic and Bone tissue engineering graft substitutes: what is the future?10.1016/j.injury.2020.07.040 ↗
3. Advancing tissue engineering: a tale of nano-, micro-, and macroscale integration10.1002/smll.201501798 ↗
4. Review of emerging nanotechnology in bone regeneration: progress, challenges, and perspectives10.1039/D1NR01371H ↗
5. Osteoconductive and osteoinductive surface modifications of biomaterials for bone regeneration: a concise review10.3390/coatings10100971 ↗
6. Surface modification techniques to produce micro/nano-scale topographies on Ti-based implant surfaces for improved osseointegration10.3389/fbioe.2022.835008 ↗
7. Strategies to improve bone healing: innovative surgical implants meet nano-/micro-topography of bone scaffolds10.3390/biomedicines9070746 ↗
8. The role of confined collagen geometry in decreasing nucleation energy barriers to intrafibrillar mineralization10.1038/s41467-018-03041-1 ↗
9. Natural and synthetic nanopores directing osteogenic differentiation of human stem cells10.1016/j.nano.2019.01.018 ↗
10. Bone regeneration: a novel osteoinductive function of spongostan by the interplay between its nano- and microtopography10.3390/cells9030654 ↗
11. The control of human mesenchymal cell differentiation using nanoscale symmetry and disorder10.1038/nmat2013 ↗
12. Recent advances in functional nanostructured materials for bone-related diseases10.1039/C8TB02812E ↗
13. Novel inorganic nanomaterial-based therapy for bone tissue regeneration10.3390/nano11030789 ↗
14. Comprehensive survey on nanobiomaterials for bone tissue engineering applications10.3390/nano10102019 ↗
15. Stem cell fate dictated solely by altered nanotube dimension10.1073/pnas.0813200106 ↗
16. Nanosize and vitality: TiO2 nanotube diameter directs cell fate10.1021/nl070678d ↗
17. Nanopillared chitosan/gelatin films: a biomimetic approach for improved osteogenesis10.1021/acsbiomaterials.9b00426 ↗
18. Effect of nanoparticle incorporation and surface coating on mechanical properties of bone scaffolds: a brief review10.3390/jfb7030018 ↗
19. Bio-mimicking nano and micro-structured surface fabrication for antibacterial properties in medical implants10.1186/s12951-017-0306-1 ↗
20. Biomaterials against bone infection
21. Nanostructured surface topographies have an effect on bactericidal activity10.1186/s12951-018-0347-0 ↗
22. Bone biomaterials for overcoming antimicrobial resistance: advances in non-antibiotic antimicrobial approaches for regeneration of infected osseous tissue10.1016/j.mattod.2020.12.018 ↗
23. Metal-based nanoparticles for bone tissue engineering10.1002/term.3131 ↗
24. Functions and applications of metallic and metallic oxide nanoparticles in orthopedic implants and scaffolds10.1002/jbm.b.34688 ↗
25. Recent advances of magnetic nanomaterials in bone tissue repair10.3389/fchem.2020.00745 ↗
26. 3D printing of micro- and nanoscale bone substitutes: a review on technical and translational perspectives10.2147/IJN.S311001 ↗
27. In vivo biofunctionalization of titanium patient-specific implants with nano hydroxyapatite and other nano calcium phosphate coatings: a systematic review10.1016/j.jcms.2015.12.004 ↗
28. Carbon nanotube-based biomaterials for orthopaedic applications10.1039/D0TB01440K ↗
29. Utilization of carbon nanotubes in manufacturing of 3D cartilage and bone scaffolds10.3390/ma13184039 ↗
30. Injectable nanocomposite hydrogels as an emerging platform for biomedical applications: a review10.1016/j.msec.2021.112489 ↗
31. Targeted nanomedicines for the treatment of bone disease and regeneration10.1002/med.21759 ↗
32. Superparamagnetic iron oxide nanoparticles-current and prospective medical applications10.3390/ma12040617 ↗
33. Recent trends in the application of widely used natural and synthetic polymer nanocomposites in bone tissue regeneration10.1016/j.msec.2020.110698 ↗
34. Natural polymeric scaffolds in bone regeneration10.3389/fbioe.2020.00474 ↗
35. Progress and prospects of polymer-based drug delivery systems for bone tissue regeneration10.3390/polym12122881 ↗
36. Bone-targeting dendrimer for the delivery of methotrexate and treatment of bone metastasis10.1080/1061186X.2018.1434659 ↗
37. Application of nanoparticles in drug delivery for the treatment of osteosarcoma: focussing on the liposomes
38. Smart cargo delivery system based on mesoporous nanoparticles for bone disease diagnosis and treatment10.1002/advs.202004586 ↗
39. Bone-targeted drug delivery systems and strategies for treatment of bone metastasis10.1248/cpb.c20-00017 ↗
40. Bisphosphonate-based nanocomposite hydrogels for biomedical applications
41. Biomaterial-assisted local and systemic delivery of bioactive agents for bone repair10.1016/j.actbio.2019.01.060 ↗
42. Nanocomposite hydrogels stabilized by self-assembled multivalent bisphosphonate-magnesium nanoparticles mediate sustained release of magnesium ion and promote in-situ bone regeneration10.1016/j.actbio.2017.09.039 ↗
43. Highly dynamic nanocomposite hydrogels self-assembled by metal ion-ligand coordination
44. Targeted delivery to bone and mineral deposits using bisphosphonate ligands10.1016/j.addr.2015.10.005 ↗
45. Binding of tetracyclines to bone10.1038/208787a0 ↗
46. Synthesis of β-estradiol-3-benzoate-17-(succinyl-12A-tetracycline): a potential bone-seeking estrogen10.1016/S0960-894X(01)80365-6 ↗
47. Tetracycline-grafted PLGA nanoparticles as bone-targeting drug delivery system
48. The nature and significance of osteopontin10.3109/03008208909002412 ↗
49. The primary structure of a cell-binding bone sialoprotein10.1016/S0021-9258(19)77651-0 ↗
50. Binding of bone sialoprotein, osteopontin and synthetic polypeptides to hydroxyapatite10.3109/03008200109014246 ↗
51. Synthesis and in vitro hydroxyapatite binding of peptides conjugated to calcium-binding moieties10.1021/bm070121s ↗
52. Aspartic acid-based modified PLGA-PEG nanoparticles for bone targeting: in vitro and in vivo evaluation10.1016/j.actbio.2014.07.015 ↗
53. Biomimetic hydrogels for controlled biomolecule delivery to augment bone regeneration10.1016/j.addr.2012.03.010 ↗
54. Nanocomposites drug delivery systems for the healing of bone fractures10.1016/j.ijpharm.2020.119477 ↗
55. Bone tissue engineering via growth factor delivery: from scaffolds to complex matrices10.1093/rb/rby013 ↗
56. Nanocarrier-based drug delivery systems for bone cancer therapy: a review10.1088/1748-605X/abf7d5 ↗
57. Recent advances in nanotechnology-based diagnosis and treatments of human osteosarcoma10.3390/bios11020055 ↗
58. Targeting nanoparticles for diagnosis and therapy of bone tumors: opportunities and challenges10.1016/j.biomaterials.2020.120404 ↗
59. Metal-organic frameworks for on-demand pH controlled delivery of vancomycin from chitosan scaffolds10.1016/j.msec.2019.110098 ↗
60. Mesoporous silica nanoparticles/gelatin porous composite scaffolds with localized and sustained release of vancomycin for treatment of infected bone defects10.1039/C7TB01246B ↗
61. Composite scaffold obtained by electro-hydrodynamic technique for infection prevention and treatment in bone repair10.1016/j.ijpharm.2018.12.002 ↗
62. Osteogenic and antibacterial dual functions of a novel levofloxacin loaded mesoporous silica microspheres/nano-hydroxyapatite/polyurethane composite scaffold10.1016/j.gendis.2019.09.014 ↗
63. 3D scaffold with effective multidrug sequential release against bacteria biofilm10.1016/j.actbio.2016.11.028 ↗
64. Enhancing X-ray attenuation of 3D printed gelatin methacrylate (GelMA) hydrogels utilizing gold nanoparticles for bone tissue engineering applications10.3390/polym11020367 ↗
65. Tantalum oxide nanoparticles for the imaging of articular cartilage using X-ray computed tomography: visualization of ex vivo/in vivo murine tibia and ex vivo human index finger cartilage10.1002/anie.201404519 ↗
66. PEGylated tantalum nanoparticles: a metallic photoacoustic contrast agent for multiwavelength imaging of tumors10.1002/smll.201903596 ↗
67. In vivo ultrasound and photoacoustic monitoring of mesenchymal stem cells labeled with gold nanotracers10.1371/journal.pone.0037267 ↗
68. Labeling human mesenchymal stem cells with gold nanocages for in vitro and in vivo tracking by two-photon microscopy and photoacoustic microscopy10.7150/thno.5369 ↗
69. Imaging of extracellular vesicles derived from human bone marrow mesenchymal stem cells using fluorescent and magnetic labels10.2147/IJN.S159404 ↗
70. Optimized labeling of bone marrow mesenchymal cells with superparamagnetic iron oxide nanoparticles and in vivo visualization by magnetic resonance imaging10.1186/1477-3155-9-4 ↗
71. Magnetic resonance imaging tracking of human adipose derived stromal cells within three-dimensional scaffolds for bone tissue engineering10.22203/eCM.v021a25 ↗
72. The advances in nanomedicine for bone and cartilage repair10.1186/s12951-022-01342-8 ↗
73. Systemic and local toxicity of metal debris released from hip prostheses: a review of experimental approaches10.1016/j.nano.2018.01.001 ↗
74. Scientific update on nanoparticles in dentistry10.1111/idj.12394 ↗
75. Cytotoxicity of nanomaterials: using nanotoxicology to address the safety concerns of nanoparticles10.2174/2211738505666171023152928 ↗
76. In vitro and in situ experiments to evaluate the biodistribution and cellular toxicity of ultrasmall iron oxide nanoparticles potentially used as oral iron supplements10.1080/17435390.2019.1710613 ↗
77. Key for crossing the BBB with nanoparticles: the rational design10.3762/bjnano.11.72 ↗
78. Crossing the blood-brain barrier with nanoparticles10.1016/j.jconrel.2017.12.015 ↗
79. The effect of nanoparticle size on the ability to cross the blood-brain barrier: an in vivo study10.2217/nnm-2017-0022 ↗
80. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration10.1016/j.biomaterials.2007.12.037 ↗
81. Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration10.1016/j.ejpb.2010.12.029 ↗
82. Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size10.1016/j.colsurfb.2008.07.004 ↗
83. Neurotoxicity of metal-containing nanoparticles and implications in glial cells10.1002/jat.4037 ↗
84. Double-edged sword: therapeutic efficacy versus toxicity evaluations of doped titanium implants10.1016/j.drudis.2021.07.004 ↗
85. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles10.1016/j.ijpharm.2005.10.010 ↗
86. Cathepsin L digestion of nanobioconjugates upon endocytosis10.1021/nn9006994 ↗
87. Cellular toxicity of inorganic nanoparticles: common aspects and guidelines for improved nanotoxicity evaluation10.1016/j.nantod.2011.08.001 ↗
88. Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties10.1021/nn800511k ↗
89. Role of oxidative stress in nanoparticles toxicity10.1080/10715762.2020.1859108 ↗
90. Cytotoxicity, oxidative stress, and autophagy effects of tantalum nanoparticles on mc3t3-E1 mouse osteoblasts10.1166/jnn.2020.17158 ↗
91. Nanotoxicity: an interplay of oxidative stress, inflammation and cell death10.3390/nano5031163 ↗
92. Toxicity and mechanisms of action of titanium dioxide nanoparticles in living organisms10.1016/j.jes.2018.06.010 ↗
93. Biosensing approaches for rapid genotoxicity and cytotoxicity assays upon nanomaterial exposure10.1002/smll.201201593 ↗
94. Thermodynamic parameters at bio-nano interface and nanomaterial toxicity: a case study on bsa interaction with ZnO, SiO2, and TiO210.1021/acs.chemrestox.9b00468 ↗
95. Ultrasonic dispersion of nanoparticles for environmental, health and safety assessment--issues and recommendations10.3109/17435390.2010.528846 ↗
96. Toxicity assessment of nanomaterials: methods and challenges10.1007/s00216-010-3996-x ↗
97. The status of in vitro toxicity studies in the risk assessment of nanomaterials10.2217/nnm.09.40 ↗
98. The effect of sedimentation and diffusion on cellular uptake of gold nanoparticles10.1038/nnano.2011.58 ↗
99. Quantitative analysis of the deposited nanoparticle dose on cell cultures by optical absorption spectroscopy10.2217/nnm-2016-0243 ↗
100. Three-dimensional models for in vitro nanotoxicity testing